Cargando…

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?

Hepatitis A vaccination stimulates memory cells to produce an anamnestic response. In this study, we used a mathematical model to examine how long-term immune memory might convey additional protection against clinical/icteric infections. Dynamic and decision models were used to estimate the expected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curran, Desmond, de Ridder, Marc, Van Effelterre, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137541/ https://www.ncbi.nlm.nih.gov/pubmed/27428611 http://dx.doi.org/10.1080/21645515.2016.1203495

Ejemplares similares

Deconstructing Community for Conservation: Why Simple Assumptions are Not Sufficient
por: Waylen, Kerry Ann, et al.
Publicado: (2013)

Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease
por: Younossi, Zobair, et al.
Publicado: (2017)

Sharp bounds on sufficient-cause interactions under the assumption of no redundancy
por: Lee, Wen-Chung
Publicado: (2017)

Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?
por: Lamberti, Monica, et al.
Publicado: (2015)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

Erratum to: Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?
por: Lamberti, Monica, et al.
Publicado: (2016)

Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments
por: Zutshi, Shubhranshu, et al.
Publicado: (2019)

Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany
por: Curran, Desmond, et al.
Publicado: (2021)

Budget constraint and vaccine dosing: a mathematical modelling exercise
por: Standaert, Baudouin A, et al.
Publicado: (2014)

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
por: McGirr, Ashleigh, et al.
Publicado: (2019)

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement
por: Hogea, Cosmina, et al.
Publicado: (2015)

Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
por: Giannelos, Nikolaos, et al.
Publicado: (2023)

Assumption of linearity in dose--effect relationships.
por: Pochin, E E
Publicado: (1978)

COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
por: Wong, Martin C. S., et al.
Publicado: (2021)

Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA)
por: Schwartz, Sharon, et al.
Publicado: (2012)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?
por: Hogea, Cosmina, et al.
Publicado: (2014)

Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009–2010
por: Van Effelterre, Thierry, et al.
Publicado: (2016)

Beliefs and assumptions of university students regarding their information literacy competence (ILC)
por: Barbosa-Chacón, Jorge Winston, et al.
Publicado: (2017)

Estimated Public Health Impact of the Recombinant Zoster Vaccine
por: Patterson, Brandon J., et al.
Publicado: (2021)

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
por: Curran, Desmond, et al.
Publicado: (2019)

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium
por: Postma, Maarten J., et al.
Publicado: (2023)

Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme
por: van Oorschot, Desirée A M, et al.
Publicado: (2019)

Dynamics of the Humoral Immune Response to a Prime-Boost Ebola Vaccine: Quantification and Sources of Variation
por: Pasin, Chloé, et al.
Publicado: (2019)

Burden‐of‐illness vaccine efficacy
por: Callegaro, Andrea, et al.
Publicado: (2020)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
por: Curran, Desmond, et al.
Publicado: (2017)

Risk, Trust, and Flawed Assumptions: Vaccine Hesitancy During the COVID-19 Pandemic
por: Ebrahimi, Omid V., et al.
Publicado: (2021)

Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists
por: Resende, Vera Lúcia S, et al.
Publicado: (2010)

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
por: Teng, Lida, et al.
Publicado: (2022)

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection
por: Hogea, Cosmina, et al.
Publicado: (2015)

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
por: Shiragami, Makoto, et al.
Publicado: (2019)

COVID-19 Vaccination is not a Sufficient Public Policy to face Crisis Management of next Pandemic Threats
por: Coccia, Mario
Publicado: (2022)

Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania
por: Hsiao, Amber, et al.
Publicado: (2023)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)
por: Gosset, Andréa, et al.
Publicado: (2021)

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
por: Thompson, Kimberly M., et al.
Publicado: (2019)

RNAi – Is one suffix sufficient?
por: Doran, Graeme
Publicado: (2007)

An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine
por: Van Regenmortel, Marc H. V.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1kju1b4kkrh9pv16s2ug09c79u